Cargando…
Killing Two Birds With One Stone: Successful Management With Rituximab in the Coexistence of Myasthenia Gravis and Marginal Zone Lymphoma
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by motor weakness affecting various muscle groups. The simultaneous or sequential occurrence of lymphoma and MG, often seen in patients, could be influenced by common genetic and biological factors that drive unregulated ly...
Autores principales: | Li, Xiao, Gaibor, Carlos, Fesler, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598348/ https://www.ncbi.nlm.nih.gov/pubmed/37885504 http://dx.doi.org/10.7759/cureus.45877 |
Ejemplares similares
-
Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis
por: Verma, Neha, et al.
Publicado: (2021) -
Coexistence of Pernicious Anemia and Myasthenia Gravis Presenting As Dyspnea
por: Khademolhosseini, Sara, et al.
Publicado: (2021) -
Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis
por: Bastakoti, Sanjiv, et al.
Publicado: (2021) -
Rituximab treatment in myasthenia gravis
por: Vesperinas-Castro, Ana, et al.
Publicado: (2023) -
Coexistence of myasthenia gravis and pemphigus foliaceus.
por: Kim, H. T., et al.
Publicado: (1995)